NDC 51662-1269
VERAPAMIL HCI
Verapamil Hci
VERAPAMIL HCI is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Hf Acquisition Co Llc, Dba Healthfirst. The primary component is Verapamil Hydrochloride.
| Product ID | 51662-1269_76112f5f-ce5e-ec60-e053-2a91aa0aae4e |
| NDC | 51662-1269 |
| Product Type | Human Prescription Drug |
| Proprietary Name | VERAPAMIL HCI |
| Generic Name | Verapamil Hci |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2018-09-17 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA070737 |
| Labeler Name | HF Acquisition Co LLC, DBA HealthFirst |
| Substance Name | VERAPAMIL HYDROCHLORIDE |
| Active Ingredient Strength | 3 mg/mL |
| Pharm Classes | P-Glycoprotein Inhibitors [MoA],Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |